The FDA today has made Zolgensma, a Novartis treatment for the rare genetic disease spinal muscular atrophy, the second approved gene therapy in the US.
Founder, The Haul Company
Founder, Young Inventors
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Medical College of Wisconsin director of research commercialization
BioClarity, which sells plant-based skincare products to online shoppers, announced Wednesday that it has raised a $13 million investment round.
The San Diego-based company is part of Adigica Health, an e-commerce company founded in 2016 to develop and market direct-to-consumer healthcare... Read more »
CrowdStrike, the cybersecurity company that identified the two Russian government-linked hacker groups that invaded the Democratic National Committee (DNC)’s network during the 2016 presidential campaign, filed publicly for an initial public offering on Tuesday.
Sunnyvale, CA-based CrowdStrike sells cloud-based security... Read more »
With Uber’s long-awaited IPO, Facebook’s mounting controversies, and ongoing debates over drug pricing and safety issues, come a great responsibility. A big story in the innovation community now is about the ethics and regulation of tech and life sciences. What are... Read more »
Danish pharma firm Lundbeck has agreed to acquire Abide Therapeutics for $250 million upfront.
The La Jolla-CA-based company, spun out of research from The Scripps Research Institute (TSRI), is developing drugs to treat diseases of the central nervous system, among them... Read more »
America continues to suffer from healthcare headaches. Our convoluted private-public insurance system was under scrutiny this week from Democrats, holding a “Medicare for All” hearing in the House, and from Republicans, as several GOP-led states and the Trump administration asked... Read more »
The first new class of migraine drugs in decades won FDA approval last year. But the companies who commercialized these new therapies and their potential competitors are already planning new, more convenient versions, taken as pills instead of injectoins just... Read more »
We at Xconomy are excited to announce that we are honoring Ivor Royston, co-founder of Hybritech and Idec Pharmaceuticals, with our 2019 Lifetime Achievement Award—the first ever awarded in San Diego. The award recognizes Royston’s wide-ranging career as an academic... Read more »
Founder and CEO, eFFECTOR Therapeutics
Founder, Science Applications International Corp. Inc.
Former President and CEO, Regulus Therapeutics
Founding Director of Calit2
CEO and Co-Founder, Receptos
Professor, Gene Expression Laboratory, Salk Institute
Managing Director, DaggerBoard Advisors
Founding Managing Partner, Forward Ventures
Professor, Laboratory of Genetics, Salk Institute